MIAMI, July 27, 2023 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of ...
"Decreasing AMMO [active maximal mouth opening] over time is seen most often in patients with SMA type 2 with an estimated reduction of almost 1 mm per year...At this point, we propose that ...
Dr. Wendy Huang, CEO and Chairperson of AnnJi, hosts the "Patient & Family Forum" at the 2026 KDA Conference. By engaging in deep dialogue regarding lived expertise and clinical care with the global ...
Dr. Amanda C. Guidon: A 60-year-old man was evaluated in the neurology clinic of this hospital because of weakness and difficulty chewing. Six months before this presentation, weakness developed in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results